Thermo Fisher Scientific, GXO Logistics And A Financial Stock On CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
On CNBC's 'Halftime Report Final Trades,' analysts highlighted GXO Logistics, Thermo Fisher Scientific, and Nasdaq, Inc. GXO posted better-than-expected Q4 results and received an upgrade from Exane BNP Paribas. Thermo Fisher is expected to report a decrease in earnings and revenue for Q1 2024. Nasdaq is anticipated to post earnings of 65 cents per share for Q1, with Goldman Sachs upgrading it to Buy. Shares of GXO fell, while Thermo Fisher and Nasdaq saw gains.
April 04, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Thermo Fisher Scientific is expected to report a decrease in earnings and revenue for Q1 2024, but shares rose slightly.
The expected decrease in earnings and revenue typically signals potential challenges, which could concern investors. However, the slight increase in share price suggests some investor optimism or other factors at play.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
GXO Logistics posted better-than-expected Q4 results and was upgraded by Exane BNP Paribas, despite a slight share price drop.
The positive earnings report and analyst upgrade indicate strong performance and potential for growth, which could lead to an increase in investor confidence despite the recent share price drop.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Nasdaq is expected to post solid Q1 earnings, with an upgrade from Goldman Sachs. Shares experienced a modest gain.
The anticipated strong Q1 earnings and the upgrade from Goldman Sachs suggest a positive outlook for Nasdaq, which likely contributed to the modest gain in share price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90